Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: Implications for the antiglaucoma properties of marihuana

Molecular Brain Research

Volumn 58, Issue 1-2, 1998, Pages 240-245

  Porcella, Anna ^a   Casellas, Pierre ^b   Gessa, Gian Luigi ^a   Pani, Luca ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b SANOFI   (France)

Author keywords

CB; Eye; Gene expression; Glaucoma; RT PCR; THC

Indexed keywords

CANNABINOID RECEPTOR; CANNABIS; MESSENGER RNA; CANNABINOID; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR CB2, RAT; COMPLEMENTARY DNA; DRUG RECEPTOR;

ANIMAL TISSUE; ARTICLE; CHOROID; CILIARY BODY; CONTROLLED STUDY; INTRAOCULAR PRESSURE; IRIS; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; COMPARATIVE STUDY; GENETIC TRANSCRIPTION; GENETICS; GLAUCOMA; HUMAN; METABOLISM; SPLEEN;

ANIMALS; CANNABINOIDS; CANNABIS; CHOROID; CILIARY BODY; DNA, COMPLEMENTARY; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; IRIS; ORGAN SPECIFICITY; RATS; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RETINA; RNA, MESSENGER; SPLEEN; TRANSCRIPTION, GENETIC;

EID: 0032527232     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00105-3     Document Type: Article

References (26)

1. J.C. Merritt, Glaucoma, hypertension, and marijuana, J. Natl. Med. Assoc. 74 (1982) 715-716.
2. G.G. Nahas, The medical use of cannabis, in: G.G. Nahas (Ed.), Marihuana in Science and Medicine, Raven Press, New York, 1984, pp. 247-261.
3. B.R. Martin, Cellular effects of cannabinoids, Pharmacolog. Rev. 38 (1986) 45-74.
4. A. Lynn, M. Herkenham, Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids, J. Pharmacol. Exp. Therap. 268 (1994) 1612-1623.
5. D.W. Pate, K. Järvinen, A. Urtti, D. Jarho, M. Fich, V. Mahadevan, T. Järvinen, Effects of topical anandamides on intraocular pressure in normotensive rabbits, Life Science 21 (1996) 1849-1860.
6. L.C. Hodges, P.H. Reggio, K. Green, Evidence against cannabinoid receptor involvement in intraocular pressure effects of cannabinoids in rabbits, Ophthalmic Res. 29 (1997) 1-5.
7. S. Galiègue, S. Mary, J. Marchand, D. Dussossoy, D. Carrière, P. Carayon, M. Bouaboula, D. Shire, G. Le Fur, P. Casellas, Expression of central and peripheral cannabinoid receptor in human immune tissues and leukocyte subpopulations, Eur. J. Biochem. 232 (1995) 54-61.
8. W.A. Devane, F.A. Dysarz, M.R. Johnson, L.S. Melvin, A.C. Howelett, Determination and characterization of cannabinoid receptor in rat brain, Mol. Pharmacol. 34 (1988) 605-613.
9. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, T.I. Bonner, Structure of cannabinoid receptor and functional expression of the cloned cDNA, Nature 346 (1990) 561-564.
10. S. Munro, K.L. Thomas, M. Abu-Shar, Molecular Characterization of a peripheral receptor for cannabinoids, Nature 365 (1993) 61-65.
11. P. Chomczynski, N. Sacchi, Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162 (1987) 156-159.
12. M. Bouaboula, M. Rinaldi, P. Carayon, C. Carillon, B. Delpech, D. Shire, G. Le Fur, P. Casellas, Cannabinoid-receptor expression in human leukocytes, Eur. J. Biochem 214 (1993) 173-180.
13. L.D. Murphy, C.E. Herzog, J. Rudick, A.T. Fojo, S.E. Bates, Use of the polymerase chain reaction in the quantitation of the mdr-1 gene expression, Biochemistry 29 (1990) 10351-10356.
14. D.W. Pate, K. Järvinen, A. Urtti, D. Jarho, T. Järvinen, Arachidonylethanolamide decreases intraocular pressure in normotensive rabbits, Curr. Eye Res. 14 (1995) 791-797.
15. K. Green, K. Kim, Interaction of adrenergic antagonists with prostaglandins E2 and tetrahydrocannabinol in the eye, Invest. Ophtalmol. 15 (1976) 102-112.
16. M.D. Randall, D.A. Kendall, Endocannabinoids: a new class of vasoactive substances, TiPS 19 (1998) 55-58.
17. J.A. Wagner, K. Varga, E.F. Ellis, B.A. Rzigalinski, B.R. Martin, G. Kunos, Activation of peripheral CB1 cannabinoid receptors in haemorragic shock, Nature 390 (1997) 518-521.
18. N.E. Buckley, S. Hansson, G. Harta, E. Mezey, Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat, Neuroscience 82 (1998) 1131-1149.
19. P.A. Fried, The Ottawa prenatal prospective study (OPPS): methodological issues and findings - it's easy to throw the baby out with the bath water, Life Sci. 56 (1995) 2159-2168.
20. M. Navarro, P. Rubio, F. Rodriguez de Fonseca, Behavioural consequences of maternal exposure to natural cannabinoids in rats, Psychopharmacology 122 (1995) 1-14.
21. E. Schlicker, J. Timm, M. Göthert, Cannabinoid receptor-mediated inhibition of dopamine release in the retina, Naunyn-Schmiedeberg's Arch. Pharmacol. 354 (1996) 791-795.
22. S. Matsuda, N. Kanemitsu, A. Nakamura, Y. Mimura, N. Ueda, Y. Kurahashi, S. Yamamoto, Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissue, Exp. Eye Res. 64 (1997) 707-711.
23. A.C. Howlett, C. Song, B.A. Berglund, G.H. Wilken, J.J. Pigg, Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies, Mol. Pharmacol. 53 (1998) 504-510.
24. K. Tsou, S. Brown, M.C. Sañudo-Peña, K. Mackie, J.M. Walker, Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system, Neuroscience 83 (1998) 393-411.
25. J.S. Nye, S. Voglmaier, R.E. Martenson, S.H. Snyder, Myelin basic protein is an endogenous inhibitor of the high-affinity cannabinoid binding sites in brain, J. Neurochem. 50 (1988) 1170-1178.
26. E.J. Farris, J.Q. Griffith, Jr. (Eds.), The Rat in Laboratory Investigation, Hafner, New York and London, 1967, 483 pp.